Shopping Cart 0
Cart Subtotal
USD 0

Vital Therapies Inc (VTL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 750
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

Vital Therapies Inc (Vital Therapies) is a biotechnology company that discovers, develops and commercialize cell-based therapies. The company's product candidate includes ELAD system, a human-cell-based bio artificial liver treatment designed to allow the patient's own liver to regenerate or to stabilize the patient until transplant. It also provides programs for severe acute alcoholic hepatitis and alcohol induced liver decompensation, surgery-induced liver failure, fulminant liver failure, and chronic liver failure. Vital Therapies' device is used in the treatment of acute liver failure. The company has operations in the US and China. Vital Therapies is headquartered in San Diego, California, the US.

Vital Therapies Inc (VTL)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Vital Therapies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Vital Therapies Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Vital Therapies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Vital Therapies Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

Vital Therapies Inc, Medical Devices Deals, 2012 to YTD 2018 10

Vital Therapies Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

Vital Therapies Inc, Pharmaceuticals & Healthcare, Deal Details 12

Venture Financing 12

Vital Therapies Raises USD 32 Million In Venture Financing 12

Vital Therapies Raises USD 12 Million In Venture Financing 13

Vital Therapies Increases Size Of Financing To USD 100 Million 14

Vital Therapies Secures USD4.35 Million in Venture Funding 16

Equity Offering 17

Vital Therapies Plans to Raise Funds through Public Offering of Shares 17

Vital Therapies Plans to Raise USD200 Million in Public Offering of Securities 18

Vital Therapies Raises USD40.3 Million in Public Offering of Shares 19

Vital Therapies Raises USD12.2 Million in Public Offering of Shares 21

Vital Therapies Raises USD34.5 Million in Public Offering of Shares 22

Vital Therapies Completes Partial Exercise of Underwriter's Over Allotment Option of Public Offering of Shares for USD36 Million 24

Vital Therapies Completes Underwriters Exercise Of Full Over-Allotment Option Of IPO For USD 62.1 Million 26

Vital Therapies Inc-Key Competitors 28

Vital Therapies Inc-Key Employees 29

Vital Therapies Inc-Locations And Subsidiaries 30

Head Office 30

Other Locations & Subsidiaries 30

Recent Developments 31

Financial Announcements 31

Aug 07, 2018: Vital Therapies announces second quarter 2018 financial results 31

May 08, 2018: Vital Therapies Reports First Quarter 2018 Financial Results 32

Mar 13, 2018: Vital Therapies Announces Fourth Quarter and Full Year 2017 Financial Results 33

Oct 25, 2017: Vital Therapies Announces Third Quarter 2017 Financial Results 35

Aug 03, 2017: Vital Therapies Announces Second Quarter 2017 Financial Results 36

May 09, 2017: Vital Therapies Announces First Quarter 2017 Financial Results 37

Mar 07, 2017: Vital Therapies Announces Fourth Quarter and Full Year 2016 Financial Results 38

Corporate Communications 39

Dec 11, 2017: Vital Therapies Added to NASDAQ Biotechnology Index 39

Sep 06, 2017: Vital Therapies Appoints Former Receptos President and CEO Faheem Hasnain as Chairman of the Board of Directors 40

Product News 41

12/04/2017: Vital Therapies Appoints Russell J. Cox as Chief Executive Officer and Board Member Effective January 3, 2018 41

09/06/2017: Vital Therapies Appoints Former Receptos President and CEO Faheem Hasnain as Chairman of the Board of Directors 42

Clinical Trials 43

Mar 22, 2018: Vital Therapies Announces VTL-308 Reaches Enrollment Target of 150 Subjects 43

Jun 05, 2017: Vital Therapies Announces Characteristics of Early Subjects in VTL-308 Pivotal Study of ELAD System in Severe Alcoholic Hepatitis 44

Appendix 45

Methodology 45

About GlobalData 45

Contact Us 45

Disclaimer 45


List Of Figure

List of Figures

Vital Therapies Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Vital Therapies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Vital Therapies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Vital Therapies Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Vital Therapies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Vital Therapies Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7

Vital Therapies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Vital Therapies Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

Vital Therapies Inc, Medical Devices Deals, 2012 to YTD 2018 10


List Of Table

List of Tables

Vital Therapies Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2

Vital Therapies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Vital Therapies Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Vital Therapies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Vital Therapies Inc, Deals By Therapy Area, 2012 to YTD 2018 9

Vital Therapies Inc, Medical Devices Deals, 2012 to YTD 2018 10

Vital Therapies Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

Vital Therapies Raises USD 32 Million In Venture Financing 12

Vital Therapies Raises USD 12 Million In Venture Financing 13

Vital Therapies Increases Size Of Financing To USD 100 Million 14

Vital Therapies Secures USD4.35 Million in Venture Funding 16

Vital Therapies Plans to Raise Funds through Public Offering of Shares 17

Vital Therapies Plans to Raise USD200 Million in Public Offering of Securities 18

Vital Therapies Raises USD40.3 Million in Public Offering of Shares 19

Vital Therapies Raises USD12.2 Million in Public Offering of Shares 21

Vital Therapies Raises USD34.5 Million in Public Offering of Shares 22

Vital Therapies Completes Partial Exercise of Underwriter's Over Allotment Option of Public Offering of Shares for USD36 Million 24

Vital Therapies Completes Underwriters Exercise Of Full Over-Allotment Option Of IPO For USD 62.1 Million 26

Vital Therapies Inc, Key Competitors 28

Vital Therapies Inc, Key Employees 29

Vital Therapies Inc, Subsidiaries 30

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Vital Therapies Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.